• Live
    • Audio Only
  • google plus
  • facebook
  • twitter
News > Mexico

Mexico To Begin Production of CanSino COVID-19 Vaccines

  • CanSino vaccine's first batch packaged by Drugmex, Mexico, Feb. 25, 2021.

    CanSino vaccine's first batch packaged by Drugmex, Mexico, Feb. 25, 2021. | Photo: Twitter/ @marthadelgado

Published 26 February 2021

This vaccine showed 95.47 percent of effectiveness in Phase 3 of clinical trials.

Mexico's Foreign Affairs Minister Marcelo Ebrard on Thursday announced the beginning of the first massive production of the COVID-19 vaccine developed by the Chinese CanSino Biologics company.


Mexico City Approves "Ingrid Law" To Avoid Re-Victimization

The vaccine will be produced in Drugmex headquarters, a subsidiary of the Argentine company Dromex, in Queretaro.

The production will monitor the vaccine's stability and purity to ensure a safe application. So far, Mexico has pre-purchased 35 million CanSino doses. 

Phase III clinical trials' results showed that the vaccine was 95.47 percent effective after 14 days of its application.

On Feb. 11, the first CanSino batch made up of 2 million doses arrived in the country where people will be immunized with a single shot.

Having vaccinated health personnel in the first stage, Mexico began phase 2 of its immunization plan which covers over 15 million adults over 60 years of age. 

As of Friday morning, the country had confirmed 2,069,370 COVID-19 cases and 183,692 related deaths.

Post with no comments.